Abstract
While cardiac ventricle assist devices (VAD) as bridges to transplant (BTT) and destination therapies (DT) are advancing technical, medical and surgical supports for end stage heart disease collateral ethical advances have not occurred. The increasing use of elective or emergent VADs are creating unique ethical issues. This is a 12 point patient protocol to reduce potential ethical dilemmas.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
